Orphenadrine Citrate Tablet, Extended Release
Product Images NDC 82868-040

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 82868-040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

82868-040-14 (82868 040 14 Rev A 01 24)

Label for Orphenadrine Citrate Extended-Release Tablets, 100 mg, containing 14 tablets. The label states 'Rx Only' with storage instructions at controlled room temperature (20°-25°C). The product is labeled by Northwind Pharmaceuticals under Northwind Health Company, LLC, and includes barcode and lot information.*

FDA Label Image

Image (Ccdf0ccb 14f9 46c3 Bc8c 84a8b0cb48c8 01)

Chemical structure diagram of orphenadrine citrate showing molecular components of the active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.